Gabrielle Jongeneel
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 24, 2021
Early Cost-effectiveness Analysis of Risk-Based Selection Strategies for Adjuvant Treatment in Stage II Colon Cancer: The Potential Value of Prognostic Molecular Markers.Gabrielle Jongeneel, Marjolein J E Greuter, Natalia Kunst
|Mar 31, 2021
Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients.Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning
|Jan 18, 2021
Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study.Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning
|Sep 30, 2020
Model-based evaluation of the cost effectiveness of 3 versus 6 months' adjuvant chemotherapy in high-risk stage II colon cancer patients.Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning
|May 28, 2020
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN).Gabrielle Jongeneel, Marjolein J E Greuter, Felice N van Erning
|Aug 20, 2019
Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real-world data.Gabrielle Jongeneel, Thomas Klausch, Felice N van Erning
Pageof 1
